MedTrace Logo

The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia

NCT01045720 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2010-01-14

No results posted yet for this study

Summary

The goal of this research is hoping to combine traditional Chinese medicine medication and find out how to solve clozapine-induced hypersalivation, also reduce side-effect, medication compliance, improving life quality, improving social-function and reducing neopathy.

Conditions

  • Schizophrenia
  • Clozapine
  • Hypersalivation
  • Traditional Chinese Medicine

Interventions

DRUG

Suo Quan Wan, Wu Lin San

Suo Quan Wan Wu Lin San Placebo 2/daily

DRUG

Placebo

Placebo (starch)

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Tsuo-Hung Lan, MD., PhD. · Taichung Veterans General Hospital

  • Tsuo-Hung Lan, MD.,PhD · Taichung Veterans General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01045720 on ClinicalTrials.gov